Travel health company Air Doctor, one of PhocusWire’s Hot 25 Travel Startups for 2021, has raised $20 million to power expansion efforts.
The new funding comes as part of the company’s Series B round led by aMoon with participation from Tokio Marine Holdings, Samsung Ventures and current shareholders Lightspeed Venture Partners, Phoenix Insurance, Munich Re Ventures and Vintage Investment Partners.
Since its launch in 2018, Air Doctor has built a network of 20,000 multilingual doctors and healthcare specialists in 84 countries across the world as it aims to give travelers access to doctors who speak their language at the “push of a button.” The company said it is now working to bolster its presence in Asia.
Jenny Cohen Derfler, CEO and founder of Air Doctor, said the company is excited to have the support of investors who share its vision.
“Diversity is in our DNA. Our success is driven by our founding and executive team spanning eight countries, representing a wide range of ethnicities,” Derfler said. “With this funding, our innovative team and our fully digital solution, Air Doctor is primed to become the standard for travelers’ and expats’ health needs worldwide.”
Subscribe to our newsletter below
Air Doctor’s app is available 24/7 in 21 languages, connecting travelers with doctors online or for in-person appointments.
“The enjoyment of traveling abroad should not be affected by lack of appropriate local healthcare options and a lengthy and costly insurance claim process. Air Doctor ensures healthcare is easy to access for travelers, while reducing exorbitant medical bills usually footed by insurers,” Derfler said.
And said Todd Sone, general partner at aMoon, “We pride ourselves on investing in cutting-edge technologies that transform industries, and Air Doctor is doing just that by leveraging advanced algorithms and app-based solutions to provide timely, quality medical care for travelers worldwide. Their fully digital platform not only offers immediate medical support but also streamlines services for healthcare providers and insurers. By reducing unnecessary referrals, it helps cut costs and relieve pressure on congested medical systems. It’s a game-changer for everyone, and we’re fully aligned with their mission.”
The company received $7.8 million in its Series A funding round in 2020.
